Efficiency of prostate-specific antigen and digital rectal examination in screening, using 4.0 ng/ml and age-specific reference range as a cutoff for abnormal values.
about
Critical evaluation of urinary markers for bladder cancer detection and monitoringThe value of current diagnostic tests in prostate cancer screening.[-2]Proenzyme prostate specific antigen is more accurate than total and free prostate specific antigen in differentiating prostate cancer from benign disease in a prospective prostate cancer screening studyGene methylation and early detection of genitourinary cancer: the road ahead.Controversies regarding screening for prostate cancer.Modeling Disease Progression with Longitudinal Markers.Detection of prostate cancer using a voltammetric electronic tongue.An abnormal digital rectal examination is an independent predictor of Gleason > or =7 prostate cancer in men undergoing initial prostate biopsy: a prospective study of 790 men.Urine cytology and urine-based markers for bladder urothelial carcinoma detection and monitoring: developments and future prospects.Clinico-pathological Correlation of Digital Rectal Examination Findings Amongst Nigerian Men with Prostatic Diseases: A Prospective Study of 236 Cases.The role of an abnormal prostate-specific antigen level and an abnormal digital rectal examination in the diagnosis of prostate cancer: A cross-sectional study in Qatar.Prostate cancer screening by prostate-specific antigen (PSA); a relevant approach for the small population of the Cayman Islands.Prostate Cancer Screening.Digital Rectal Examination for Prostate Cancer Screening in Primary Care: A Systematic Review and Meta-Analysis.Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy
P2860
Q24654929-A3E57CC3-9C39-4921-9460-A88472F843D8Q34394012-402AB202-DB4A-4118-A82B-27545D4624ECQ36509148-796A4A56-FAF7-4097-811C-85B97C30755DQ36856466-A1E5766B-1B23-4689-B1A6-6E1F14F0C84FQ36861719-7D5D5849-A825-4381-8274-FD7240C7D211Q37496290-D4AE335E-C278-47A8-ABD2-2E5F5CA95234Q39634745-E8A754E2-FB67-4557-B84A-BB3AC408B6A0Q39777849-600268C9-338E-41F3-9C51-0E267F3B524DQ40109451-29A697C7-1D27-41DC-B0EC-D181E48CC8A4Q40136506-910AB853-9282-400C-B843-301D8426B57BQ40329660-71C3BC7A-70DC-4260-B4D6-332D90024631Q50055248-CFB1331E-FDDD-41EB-B7CB-284F40D63611Q52698894-51D8C1D8-99FC-45CA-8D20-84597E793766Q53274562-00D625B2-A87E-48B9-B783-FA3F5B83AB75Q57239036-8E6BB27C-3B10-446F-B290-8B8050654747
P2860
Efficiency of prostate-specific antigen and digital rectal examination in screening, using 4.0 ng/ml and age-specific reference range as a cutoff for abnormal values.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Efficiency of prostate-specifi ...... a cutoff for abnormal values.
@en
Efficiency of prostate-specifi ...... a cutoff for abnormal values.
@nl
type
label
Efficiency of prostate-specifi ...... a cutoff for abnormal values.
@en
Efficiency of prostate-specifi ...... a cutoff for abnormal values.
@nl
prefLabel
Efficiency of prostate-specifi ...... a cutoff for abnormal values.
@en
Efficiency of prostate-specifi ...... a cutoff for abnormal values.
@nl
P2093
P1433
P1476
Efficiency of prostate-specifi ...... a cutoff for abnormal values.
@en
P2093
Crawford ED
Holthaus K
Leewansangtong S
P304
P356
10.1002/(SICI)1097-0045(19990301)38:4<296::AID-PROS5>3.0.CO;2-P
P577
1999-03-01T00:00:00Z